ACITRETIN - परिणामों की खोज

कनाडा - अंग्रेज़ी - Health Canada

taro-acitretin capsule

taro pharmaceuticals inc - acitretin - capsule - 10mg - acitretin 10mg - misc. skin and mucous membrane agents

कनाडा - अंग्रेज़ी - Health Canada

taro-acitretin capsule

taro pharmaceuticals inc - acitretin - capsule - 25mg - acitretin 25mg - misc. skin and mucous membrane agents

कनाडा - अंग्रेज़ी - Health Canada

mint-acitretin capsule

mint pharmaceuticals inc - acitretin - capsule - 10mg - acitretin 10mg - misc. skin and mucous membrane agents

कनाडा - अंग्रेज़ी - Health Canada

mint-acitretin capsule

mint pharmaceuticals inc - acitretin - capsule - 25mg - acitretin 25mg - misc. skin and mucous membrane agents

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

soriatane- acitretin capsule

stiefel laboratories inc - acitretin (unii: lch760e9t7) (acitretin - unii:lch760e9t7) - acitretin 10 mg - soriatane is indicated for the treatment of severe psoriasis in adults. because of significant adverse effects associated with its use, soriatane should be prescribed only by those knowledgeable in the systemic use of retinoids. in females of reproductive potential, soriatane should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed contraindications and warnings — soriatane can cause severe birth defects). most patients experience relapse of psoriasis after discontinuing therapy. subsequent courses, when clinically indicated, have produced efficacy results similar to the initial course of therapy. see boxed contraindications and warnings. soriatane is contraindicated in patients with severely impaired liver or kidney function and in patients with chronic abnormally elevated blood lipid values (see boxed warnings:hepatotoxicity, warnings:lipids and possible cardiovascular effects, and precautions). an